Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 4 (1)

Trial Status

Unknown2
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06272357Not Yet RecruitingPrimary

The Use of Antiarrhythmic Drugs in Pediatrics

NCT05902676Unknown

The Effects Of Anticholinergic Burden On Daily Living Activities In Elderly Patients

NCT05418036Phase 4Unknown

Safety Assessment for Sotalol Protocol in Outpatient Unit

Showing all 3 trials

Research Network

Activity Timeline